Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Standard

Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation : An Update on Current Knowledge. / Sabbah, Muhammad; Engstrøm, Thomas; De Backer, Ole; Søndergaard, Lars; Lønborg, Jacob.

I: Frontiers in Cardiovascular Medicine, Bind 8, 654892, 2021.

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Harvard

Sabbah, M, Engstrøm, T, De Backer, O, Søndergaard, L & Lønborg, J 2021, 'Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge', Frontiers in Cardiovascular Medicine, bind 8, 654892. https://doi.org/10.3389/fcvm.2021.654892

APA

Sabbah, M., Engstrøm, T., De Backer, O., Søndergaard, L., & Lønborg, J. (2021). Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge. Frontiers in Cardiovascular Medicine, 8, [654892]. https://doi.org/10.3389/fcvm.2021.654892

Vancouver

Sabbah M, Engstrøm T, De Backer O, Søndergaard L, Lønborg J. Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge. Frontiers in Cardiovascular Medicine. 2021;8. 654892. https://doi.org/10.3389/fcvm.2021.654892

Author

Sabbah, Muhammad ; Engstrøm, Thomas ; De Backer, Ole ; Søndergaard, Lars ; Lønborg, Jacob. / Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation : An Update on Current Knowledge. I: Frontiers in Cardiovascular Medicine. 2021 ; Bind 8.

Bibtex

@article{e0c64b13e8104131be0af85202cc8ef7,
title = "Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation: An Update on Current Knowledge",
abstract = "Transcutaneous aortic valve implantation (TAVI) has led to a paradigm shift in the treatment of severe aortic stenosis (AS) in the elderly and is expanding to still younger and lower-risk patients with severe AS as an alternative to surgical aortic valve replacement (SAVR). While the role of coronary artery bypass grafting with SAVR is well-documented, the analog of percutaneous coronary intervention with TAVI is less so. The aim of this review is to provide an overview of the important challenges in treating severe AS and co-existing coronary artery disease in patients planned for TAVI.",
keywords = "transcatheter aortic valve implantation, percutaneous coronary intervention, revascualrization, fractional flow reserve, coronary artery diasease, FRACTIONAL FLOW RESERVE, ELEVATION MYOCARDIAL-INFARCTION, OUTCOME SOURCE REGISTRY, VALVULAR HEART-DISEASE, ARTERY-DISEASE, FUNCTIONAL SEVERITY, EUROPEAN REGISTRY, CLINICAL-OUTCOMES, GUIDED PCI, OPEN-LABEL",
author = "Muhammad Sabbah and Thomas Engstr{\o}m and {De Backer}, Ole and Lars S{\o}ndergaard and Jacob L{\o}nborg",
year = "2021",
doi = "10.3389/fcvm.2021.654892",
language = "English",
volume = "8",
journal = "Frontiers in Cardiovascular Medicine",
issn = "2297-055X",
publisher = "Frontiers Media",

}

RIS

TY - JOUR

T1 - Coronary Assessment and Revascularization Before Transcutaneous Aortic Valve Implantation

T2 - An Update on Current Knowledge

AU - Sabbah, Muhammad

AU - Engstrøm, Thomas

AU - De Backer, Ole

AU - Søndergaard, Lars

AU - Lønborg, Jacob

PY - 2021

Y1 - 2021

N2 - Transcutaneous aortic valve implantation (TAVI) has led to a paradigm shift in the treatment of severe aortic stenosis (AS) in the elderly and is expanding to still younger and lower-risk patients with severe AS as an alternative to surgical aortic valve replacement (SAVR). While the role of coronary artery bypass grafting with SAVR is well-documented, the analog of percutaneous coronary intervention with TAVI is less so. The aim of this review is to provide an overview of the important challenges in treating severe AS and co-existing coronary artery disease in patients planned for TAVI.

AB - Transcutaneous aortic valve implantation (TAVI) has led to a paradigm shift in the treatment of severe aortic stenosis (AS) in the elderly and is expanding to still younger and lower-risk patients with severe AS as an alternative to surgical aortic valve replacement (SAVR). While the role of coronary artery bypass grafting with SAVR is well-documented, the analog of percutaneous coronary intervention with TAVI is less so. The aim of this review is to provide an overview of the important challenges in treating severe AS and co-existing coronary artery disease in patients planned for TAVI.

KW - transcatheter aortic valve implantation

KW - percutaneous coronary intervention

KW - revascualrization

KW - fractional flow reserve

KW - coronary artery diasease

KW - FRACTIONAL FLOW RESERVE

KW - ELEVATION MYOCARDIAL-INFARCTION

KW - OUTCOME SOURCE REGISTRY

KW - VALVULAR HEART-DISEASE

KW - ARTERY-DISEASE

KW - FUNCTIONAL SEVERITY

KW - EUROPEAN REGISTRY

KW - CLINICAL-OUTCOMES

KW - GUIDED PCI

KW - OPEN-LABEL

U2 - 10.3389/fcvm.2021.654892

DO - 10.3389/fcvm.2021.654892

M3 - Review

C2 - 34095249

VL - 8

JO - Frontiers in Cardiovascular Medicine

JF - Frontiers in Cardiovascular Medicine

SN - 2297-055X

M1 - 654892

ER -

ID: 302073897